Marksans Pharma Ltd.

BSE: 524404 | NSE: MARKSANS |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE750C01026 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Marksans Pharm Marksans Pharma Ltd. | BSE 174.40 4.40 (2.59%) | NSE 174.60 4.60 (2.71%) | Trade | Add

BSE Live

Apr 08, 16:01

174.40 4.40 (2.59%)

Volume

AVERAGE VOLUME

5-Day

45,672

10-Day

54,669

30-Day

40,506

30,960

Prev. Close

170.00
Open Price

176.90

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Apr 08, 15:57

174.60 4.60 (2.71%)

Volume

AVERAGE VOLUME

5-Day

774,787

10-Day

914,047

30-Day

668,692

645,618

Prev. Close

170.00
Open Price

176.00

Bid Price (Qty.)
174.60 (510)
Offer Price (Qty.)
0.00 (0)

Financials

Print/Copy to Excel : Go

Balance Sheet of Marksans Pharma (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	45.32	45.32	45.32	40.93	40.93
Total Share Capital	45.32	45.32	45.32	40.93	40.93
Reserves and Surplus	1,338.17	1,177.39	1,066.01	743.74	558.79
Total Reserves and Surplus	1,338.17	1,177.39	1,066.01	743.74	558.79
Total Shareholders Funds	1,383.49	1,222.71	1,111.32	784.67	599.72
NON-CURRENT LIABILITIES
Long Term Borrowings	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liabilities [Net]	12.15	9.41	8.64	9.01	8.49
Other Long Term Liabilities	14.03	7.02	5.18	3.55	13.34
Long Term Provisions	0.00	4.47	3.18	1.86	2.11
Total Non-Current Liabilities	26.18	20.90	17.00	14.41	23.94
CURRENT LIABILITIES
Short Term Borrowings	0.00	0.00	0.00	5.00	0.00
Trade Payables	203.53	159.72	111.58	74.45	64.15
Other Current Liabilities	142.10	110.77	103.64	86.35	29.78
Short Term Provisions	0.00	1.96	1.33	0.72	0.97
Total Current Liabilities	345.64	272.44	216.54	166.53	94.90
Total Capital And Liabilities	1,755.30	1,516.04	1,344.86	965.61	718.55
ASSETS
NON-CURRENT ASSETS
Tangible Assets	380.90	268.51	140.88	131.86	124.84
Intangible Assets	2.47	3.07	3.06	3.65	4.24
Capital Work-In-Progress	0.00	0.00	3.91	0.00	0.00
Other Assets	0.00	0.00	0.00	0.00	0.00
Fixed Assets	383.37	271.58	147.85	135.51	129.09
Non-Current Investments	265.75	265.75	265.75	236.07	236.07
Deferred Tax Assets [Net]	0.00	0.00	0.00	0.00	0.00
Long Term Loans And Advances	0.00	0.00	0.00	0.00	0.00
Other Non-Current Assets	23.96	31.01	17.50	4.16	4.16
Total Non-Current Assets	673.08	568.33	431.10	375.75	369.32
CURRENT ASSETS
Current Investments	0.74	26.99	0.54	0.44	0.00
Inventories	205.21	190.85	130.95	103.68	93.69
Trade Receivables	549.58	370.17	305.49	246.78	146.79
Cash And Cash Equivalents	268.69	312.23	440.26	224.05	105.71
Short Term Loans And Advances	0.00	0.00	0.00	0.00	0.00
OtherCurrentAssets	58.00	47.46	36.52	14.92	3.05
Total Current Assets	1,082.22	947.70	913.76	589.86	349.24
Total Assets	1,755.30	1,516.04	1,344.86	965.61	718.55
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	23.89	22.06	9.31	114.36	115.10
CIF VALUE OF IMPORTS
Raw Materials	0.00	0.00	0.00	0.00	0.00
Stores, Spares And Loose Tools	0.00	0.00	0.00	0.00	0.00
Trade/Other Goods	0.00	0.00	0.00	0.00	0.00
Capital Goods	0.00	0.00	0.00	0.00	0.00
EXPENDITURE IN FOREIGN EXCHANGE
Expenditure In Foreign Currency	163.50	151.14	134.84	104.00	101.42
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS
Dividend Remittance In Foreign Currency	--	--	--	--	--
EARNINGS IN FOREIGN EXCHANGE
FOB Value Of Goods	--	--	--	--	--
Other Earnings	151.14	846.59	649.14	641.86	587.42
BONUS DETAILS
Bonus Equity Share Capital	--	--	--	--	--
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	--	--	--	--	--
Non-Current Investments Unquoted Book Value	265.75	265.75	265.75	236.07	236.07
CURRENT INVESTMENTS
Current Investments Quoted Market Value	0.74	--	--	--	--
Current Investments Unquoted Book Value	--	26.99	--	--	--